Jun Ah Lee

Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice

Anti-cancer natural products isolated from chinese medicinal herbs

Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

Sarcoma in the Young Adult Population: An International View

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

Thymoquinone and its therapeutic potentials

Osteosarcoma treatment – Where do we stand? A state of the art review

Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway

Osteosarcoma: improvement in survival limited to high-grade patients only

Promise and pitfalls of quantitative imaging in oncology clinical trials

Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

A review on therapeutic potential of Nigella sativa: A miracle herb

Long Noncoding RNA and Cancer: A New Paradigm

Functional Role of Type I and Type II Interferons in Antiviral Defense

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.

Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays

Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells

Cytokine therapeutics: lessons from interferonalpha.

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Preventing and Managing Toxicities of High-Dose Methotrexate

Osteosarcoma Developed in the Period of Maximal Growth Rate Have Inferior Prognosis

Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience

RANKL expression is related to treatment outcome of patients with localized, high‐grade osteosarcoma

Relative tumor burden predicts metastasis‐free survival in pediatric osteosarcoma

Osteosarcoma in Adolescents and Young Adults

Tumor Necrosis Rate Adjusted by Tumor Volume Change Is a Better Predictor of Survival of Localized Osteosarcoma Patients